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Introduction: Hepatitis C virus (HCV) genome contains two envelope proteins (E1 and E2) responsible for the virus
entry into the cell. There is a substantial lack of sequences covering the full length of E1/E2 region for genotype 4.
Our study aims at providing new sequences as well as characterizing the genetic divergence of the E1/E2 region of
HCV 4a using our new sequences along with all publicly available datasets.
Methods: The genomic segments covering the whole E1/E2 region were isolated from Egyptian HCV patients and
sequenced. The resulting 36 sequences 36 were analyzed using sequence analysis techniques to study variability
within and among hosts in the same time point. Furthermore, previously published HCV E1/E2 sequence datasets
for genotype 4a were retrieved and categorized according to the geographical location and date of isolation and
were used for further analysis of variability among Egyptian over a period of 15 years, also compared with non-
Egyptian sequences to figure out region-specific variability.
Results: Phylogenetic analysis of the new sequences has shown variability within the host and among different
individuals in the same time point. Analysis of the 36 sequences along with the Egyptian sequences (254 sequences
in E1 in the period from 1997 to 2010 and 8 E2 sequences in the period from 2006 to 2010) has shown temporal
change over time. Analysis of the new HCV sequences with the non-Egyptian sequences (182 sequences in E1 and
155 sequences in the E2) has shown region specific variability. The molecular clock rate of E1 was estimated to be
5E-3 per site per year for Egyptian and 5.38E-3 for non-Egyptian. The clock rate of E2 was estimated to be 8.48E per
site per year for Egyptian and 6.3E-3 for non-Egyptian.
Conclusion: The results of this study support the high rate of evolution of the Egyptian HCV genotype 4a. It has
also revealed significant level of genetic variability among sequences from different regions in the world.
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Hepatitis C Virus (HCV) is a major risk factor for liver
diseases and hepatocellular carcinomas (HCC) worldwide
[1]. Approximately, 175 million persons, representing 3%
of the whole world population, are affected worldwide.
HCV infection is now endemic in many countries. Egypt
has the highest prevalence of HCV worldwide; where 6%
to 20% of the Egyptian population are HCV positive with
an average of 13.8% [2].
HCV, which is a member of the Hepacivirus group of
the Flaviviridae family, is an enveloped virus with a sin-
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unless otherwise stated.genome encodes a single poly-protein that is cleaved
into 10 mature proteins. The structural proteins are lo-
cated near the 5' end of the poly-protein and the non-
structural proteins are located near the 3' end [4].
HCV isolates have been classified into seven genotypes
and several subtypes, differing in about 20–25% of the nu-
cleotide sequences [5,6]. HCV has a very high mutation
rate of about 10E-5 error/nt, with large genetic heterogen-
eity and variability due to the lack of any proofreading
mechanism [7]. The geographical distribution of geno-
types and subtypes differs greatly from one region to an-
other [8]. In the Middle East and Africa, HCV genotype 4
(HCV-4) is the most common genotype. In Egypt, geno-
type 4 is the most predominant genotype, and 4a is the
dominant subtype [10]. Interestingly, Genotype 4 has re-
cently spread to several European countries [9].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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in the blood of infected persons due to the high mutation
rate. The genomes of these quasispecies vary slightly and
fluctuate during the course of the disease. However, the
changes in the consensus sequence of a viral population
occur only if the population equilibrium is altered by a se-
lection mechanism. As discussed in [11], the viral variants
may be related to differences in transmissibility, immu-
nogenicity, or pathogenicity, which should be taken into
consideration in the development of prophylactic and
therapeutic vaccines.
The E1/E2 region harbors the E1 and E2 glycoproteins,
which are thought to be the viral attachment proteins.
This region demonstrates a high level of variability, espe-
cially at two sub-regions known as HVR1 and HVR2 [12].
This variability is thought to be related either to the non-
clearance of the virus or the resistance to antiviral therap-
ies [13]. This variability also poses a major challenge in
vaccine design, where the objective is the identification of
protective epitopes conserved across different strains of
HCV [14] [15].
Despite the importance of HCV E1/E2 region, very few
studies have sequenced the full length of the related se-
quence, especially for genotype 4a. From our data retrieval
work described in this paper, there are only 8 Egyptian
Genotype 4a sequences covering the E1/E2 region. The
other Egyptian sequences cover only fraction of the region.
For non-Egyptian Genotype 4a sequences, there are only 6
sequences covering the E1/E2 region and the other ones
cover only a fraction of the region. There is also no study
that analyzed all these sequences and compared them to
each other to identify temporal as well as region specific
variability.
In this paper, we have focused on the E1/E2 region and
studied its variability among Egyptian and non-Egyptian
isolates. Specifically, 1) we sequenced 36 viral genome seg-
ments from five patients with HCV genotype 4a covering
the E1/E2 region (of about 1,672 nucleotides), 2) we col-
lected all publically available sequences covering E1/E2
genotype 4a and compared them to each other and to our
new sequences considering time of isolation and geo-
graphical location, and 3) we estimated the rate of change
within the Egyptian and Non-Egyptian isolates.
Methods
Patients
The present study included five different HCV (geno-
type-4a)-infected individuals with no history of liver cir-
rhosis or end stage liver disease. A written informed
consent was obtained from each patient prior to enroll-
ment in the study and the ethical committees of Kasr el
Ainy, School of Medicine and the National Cancer insti-
tute, Cairo University approved the study protocol which
conformed to the ethical guidelines of the World MedicalAssociation Declaration of Helsinki. Serum samples were
collected from patients admitted to Viral Hepatitis Center.
Anti-HCV antibodies were detected in sera by fourth-
generation ELISA (ETI-AB-HCVK-4, DiaSorin) and in-
fection was confirmed by HCV RT-PCR. All samples
were genotyped with Versant HCV genotype assay
(LiPA) 2.0 (Innogenetics, Siemens Healthcare Diagnostics,
USA) prior to enrollment in the study.
RNA extraction and amplification of the E1/E2 genome
regions
Viral RNA was extracted from 140 μL of serum using the
Qiagen vRNA Extraction Kit according to manufacturer’s
protocol (Qiagen, Hilden, Germany). c-DNA was synthe-
sized using Reverse transcription step Kit (StrataScript®
Reverse Transcription- Stratagene, La Jolla, CA). PCR
amplification was done using the primer sequences and
PCR conditions (a nested PCR) of Dimitri et al. [16]
(Table 1). PCR cycling conditions were as follows: 95°C
for 2 min, followed by 35 cycles of 30 s at 95°C, 30 s at
50°C, 2 min at 68°C and a final extension of 68°C for
10 min using the HotStart-IT™ Taq DNA Polymerase
(USA). A second round of PCR was carried out under the
same conditions with 1 μl of the first PCR product for
28 cycles and then the PCR products were separated by
1% agarose gel electrophoresis. Fragments of the expected
size (1.7 kb) were purified out of the gel, for subsequent
cloning; using a High pure PCR product purification kit
(Roche applied science, Mannheim, Germany).
Cloning
Purified PCR products were directly ligated into pCR2.1-
TOPO plasmid (Invitrogen, Carlsbad, CA, USA) and then
chemically transformed into One Shot Top10 Escherichia
coli (Invitrogen, Carlsbad, CA, USA) according to manu-
facturer’s instructions. Bacteria were plated onto Luria
Bertani agar plates containing ampicillin (50–100 μg/ml).
Clones with E1/E2 sequences were identified by standard
blue/white screening, as well as by colony PCR and restric-
tion enzyme cut. {We used restriction enzyme maps and
applied applying the remap tool from the European bank
of bionformatics (http://srs.ebi.ac.uk/srsbin/cgi-bin/wgetz)
to the sequences of the vector and E1/E2 region. Hind III
(GibcoBRL, USA) was used for restriction enzyme cut,
with specific one target position at 234–240 bp of the vec-
tor sequence map, according to the manufacture’s proto-
col. Then, 10 μl of the digestion reaction were loaded onto
1% agarose gel, fragments were separated by electrophor-
esis and visualized by ethidium bromide staining}.
Sequencing
Sequencing of purified plasmids was performed using
the BigDye Terminator kit (Applied Biosystems, Foster
City, Calif.) according to manufacturer’s instructions in
Table 1 Primers used for the generation of E1/E2 area of HCV genotype 4
Primers Polarity Sequences (5′-3′) Application Product size
HCV outer 2 Antisense CACCAGCGGGTGAAGCAGCATTGA RT/1st round PCR
HCV outer 1 Sense GGACGGGGTAAACTATGCAACAGG 1st round PCR 1804 bp
HCV inner 2 Antisense GACAGTTACGCCTGAACTTGACTTACCATAAACATC 2nd round PCR
HCV inner 1 Sense CACCCATGGGTTGCTCTTTTTCTATC 2nd round PCR 1726 bp
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Plasmids containing E1/E2 inserts were sequenced using
a bidirectional primer walking method and sequences
were analyzed with Lasergene software (DNAStar, Inc.,
Madison, WI). On average, ten clones were sequenced
for each clinical isolate. All reads were checked for vec-
tor contamination and assembled into contiguous se-
quences using the tools from the EMBOSS package [17].
Deposition in GenBank
All the E1/E2 sequences characterized in the present
study have been submitted to GenBank under the indi-
cated accession numbers JX310279-JX310314.
Data collection from public databases
Three main databases were queried to retrieve the publicly
available HCV sequences related to the E1/E2 region:
1- NCBI GenBank (https://www.ncbi.nlm.nih.gov/
genbank), which is the major repository for
nucleotide sequences.
2- The Hepatitis C Virus Databases at LANL, Los
Alamos National Library (hcv.lanl.gov).
3- The European Hepatitis C Virus Database euHCVdb
(https://euhcvdb.ibcp.fr).
The retrieval and categorization of sequences from
LANL and euHCVdb was based on filtering the deposited
HCV sequences according to the genotype. Determining
whether a sequence is from Egypt or not and determining
its collection date were achieved by parsing the respective
GenBank file. In case of using the GenBank database, the
retrieval and categorization of sequences was achieved by
the following workflow. First, all HCV sequences were col-
lected in GenBank file formats. These files were then
parsed to filter out sequences not including Genotype 4a.
Also the filers including regions other than E1/E2 were fil-
tered out. Whole genomes with Genotype 4a are always
accepted as they include E1/E2 regions. The remaining
files (sequences) are then parsed again to categorize them
according to the location and the date of isolation. In case
of missing information, we restored to the related publica-
tions to complete the categorization. The retrieval and
categorization were accomplished using own scripts writ-
ten in Python and Perl scripting languages.Sequence analysis
Multiple sequence alignment was accomplished using the
Clustalw [18] and the MUSCLE [19] programs. We used
two distance measures for aligning pairs of sequences: the
k-mer distance (for an unaligned pair) and the Kimura dis-
tance (for an aligned pair). We wrote a program (in Perl)
to correct for sequencing errors; in this program a single
character change in a column was considered as a sequen-
cing error and it was corrected.
Preprocessing of public datasets
Except for whole genome sequences, the public sequences
cover parts of the E1/E2 region. To extract the segments
common to all sequences, we used the following work-
flow: First, we aligned the whole genomic sequences along
with our full length E1/E2 sequences using ClustalW.
Then we extracted the region covering E1/E2 from each
whole genome sequence. For the E1 region, we aligned the
other partial public sequences to the E1 sequences ob-
tained from the previous step and visualized the results
using the program JalView. From JalView, which supports
selection and editing of multiple sequence alignments, we
selected the part of E1 common to all given sequences
and extracted it to multi-Fasta file. The same steps were
conducted for pre-processing E2 public sequences.
Phylogenetic trees
Phylogenetic trees were constructed with the PhyML
package using default parameters. The Akaike’s informa-
tion criterion, implemented in JModeltest [20], was used
to find the most appropriate model of evolution. We also
used the BEAST program [21] to compute the phylogen-
etic tree under a molecular clock assumption. We labeled
each sequence with its date and used the strict and relaxed
uncorrelated lognormal clock models. The chain length
for the Monte Carlo Markov Chains (MCMC) procedure
was set to 20 millions, at least, in order to achieve a
statistically significant results with an effective sample
size (ESS) larger than 100. Data Visualization was
achieved using the FigTree (http://tree.bio.ed.ac.uk/
software/figtree/) and Cytoscape programs [22].
Variability analysis
The Nei and Gojobori method [23] implemented in the
molecular evolutionary genetics analysis software package
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etic distance (d), the number of synonymous substitutions
per synonymous site (dS), the number of non-synonymous
substitutions per nonsynonymous site (dN) and dN/dS
values.
To spot the variability within the highly variable re-
gions of the HCV E1/E2, we used the VarPlot software
tool (available from S.C.R. at http://sray.med.som.jhmi.
edu/SCRoftware) [25], which is also based on the Nei
and Gojobori method [23]. Accordingly, the values for
dS, dN and the dN/dS ratio were computed in sliding w
ws over the multiple alignments; each has a width of 20
nucleotides [25]. Two consecutive windows were over-
lapping by 19 nucleotides. At each step, the results for
all pairwise comparisons were computed and the values
were averaged. The Jukes-Cantor correction was used to
correct for underestimated distances due to multiple
substitutions at the same site [26].
Results
1-Analysis of sequencing data
After the assembly and annotation, we excluded all
clones containing nonsense and frame shift mutations as
well as the sequences that didn’t overlap well or didn’t
meet the control criteria. Accordingly, the number of
the analyzed variants was reduced to 36 out of 50, which
represents isolates from five different HCV patients. Our
dataset of 36 sequences were assembled into contiguous
sequences of about 1762 bp.
2-Alignment of informative sites
Multiple sequence alignment was computed using the
Clustalw and Muscle programs. The resulting two align-
ments were compared and curated where a single charac-
ter change in a column was considered as a sequencing
error and was corrected. This curation has removed a
number of errors and it fine-tuned the final analysis re-
sults. Multiple sequence alignment(s) of the sequences is
available in Additional file 1.
3-Phylogenetic analysis of the 36 Egyptian E1/E2
sequences
Phylogenetic trees were constructed for all sequences to
determine the diversity of variants constituting each indi-
vidual HCV population and the relationships between
them, using HCV genotype 1 sequence as the out-species.
However, to enlarge the image, the out-species was deleted
from the trees in the figures, without changes in the top-
ology of the representations. The analyzed sequences rep-
resented 36 different isolates form 5 different patients,
which were numbered from 1–10 and named (grouped or
categorized) as: A, B, C, D, and E. Then, we constructed a
phylogenetic tree for each group of sequences, which was
obtained from the same individual (Figure 1). For alldefined sequences in the phylogenetic tree of E1/E2 region
of the HCV genotype 4 sequences (36), two different
monophyletic groups were observed. Each of these groups
includes sequences from the different studied cases. One
group includes sequences that represent all of the 5 patients
and the other group includes the sequence from 4 patients
only. All sequences obtained from patient C showed high
genetic similarity, other clades showed remarkable dif-
ferences between the sequences obtained from other pa-
tients with high degree of variability and divergence among
sequences in the same individual (Figure 2).
To further assess the variability within the sequences and
the reliability of the constructed tree, the maximum likeli-
hood E estimation of substitution matrix was calculated
where each entry represents the probability of substitu-
tion (r) from one base (row) to another (column). The
substitution pattern and rates were estimated under the
Tamura-Nei (1993) model [24] (Table 2). The rates of dif-
ferent transitional substitutions are shown in bold and
those of transversional substitutions are shown in italics.
For simplicity, the sum of r values was considered equal
to 100. The nucleotide frequencies are: A = 20.14%,
T/U = 25.46%, C = 28.61% and G = 25.79%. For estimating
the Maximum log (ML) values, a user-specified topology
based on the computed tree was used. The ML likelihood
for this computation was −4230.178. The codon positions
included were 1st + 2nd + 3rd +Noncoding. The average
evolutionary divergence, which represents the number of
base substitutions per site by averaging over all sequence
pairs, was estimated to be 0.023. These results suggest a
high degree of genetic diversity within the E1/E2 region
of HCV genotype 4a.Variability analysis with the 36 Egyptian sequences
To assess the variability among the different segments of
our sequences, we performed a high-resolution analysis of
differences in dN/dS ratios using the VarPlot. We also used
the MEGA5 package to compute the mean evolutionary
rates at each site. We also wrote special Perl scripts to plot
these variations. Figure 3 shows the plots, which depict the
evolutionary rate at each site for all groups in the dataset;
we highlighted the location of the known hyper-variable re-
gions HVR1, HVR2, and HVR3 of the E1/E2. Figure 4
shows the evolutionary rates for each group separately.Public HCV datasets
We retrieved all publicly available HCV genotype 4a se-
quences from GenBank, LANL, and euHCVdb databases.
Table 3 summarizes the results of all collected sequences
from these databases. Additional file 2 includes all details
of the collected sequences, including the origin, the date
of isolation, the number of sequences, average lengths,
and the respective publications. It is clear that NCBI was
Figure 1 Predicted phylogenetic relationships for each group of sequences within the same infected individual, the scale bar represents
genetic distance (substitutions per site). Group B represent the most closely related isolates. All panels represents different patients marked as A, B,
C, D and E.
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sequences than what available in other datasets. The chal-
lenge was just to develop a workflow to structure and
categorize the data according to the origin of the se-
quences, the genotype, and the date of isolation.
In Additional file 2, we see that the E1 dataset for non-
Egyptian isolated is divided into two subsets. The reason
for this is as follows. Because most of the public sequences
cover parts of the E1/E2 region, we used the multiple
alignment based approach presented in the methodology
section to find segments common to all the sequences.
For E1, it was determined that some sequences cover the
left most part of the E1 region and other datasets cover
the right most part of the E1 region. Therefore, we com-
posed two subsets for E1 and analyzed each oneseparately. The E1 dataset covering the left most part of
the E1 region included 27 sequences from 6 countries:
Canada, France, South Africa, Pakistan, Serilanka, and
USA. The length of each sequence in the final set was
113 bp (in all the Egyptian sequences, the region starts at
position 154 and ends at position 266). The second E1 set
covering the rightmost part of E1 included 155 sequences
from two countries (Ireland and USA). The average length
of each sequence in the final set was 197 bp. (In our se-
quences, the region starts at position 421 and end at pos-
ition 617 in each sequence.). The reason why US
sequences appear in both subsets is that the US sequences
are full length viral genomes including the whole E1 re-
gion. The Ireland dataset includes sequences at the junc-
tion of E1/E2 and hence they appear on the dataset
Figure 2 Predicted phylogenetic relationships among HCV genotype 4 isolates of E1/E2 region. The scale bar represents genetic distance
(substitutions per site).
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dataset covering E2. The E2 dataset was not sub-divided
as it included the US and Ireland sequences.Table 2 Maximum likelihood estimate of substitution
matrix, substitution pattern and rates were estimated
under the Tamura-Nei (1993) model
A T/U C G
A - 3.48 3.91 16.09
T/U 2.75 - 23.29 3.52
C 2.75 20.73 - 3.52
G 12.56 3.48 3.91 -
Rates of different transitional substitutions are shown in bold and those of
transversionsal substitutions are shown in italics.Evolution of genotype 4a in Egyptian isolates
Phylogenetic trees
Figure 5 shows the phylogenetic tree for the 254 public
E1 sequences (isolated from 1997 to 2010) in addition to
our new ones. It is clear that our sequences are grouped
together. The other largest group is for a previous study
of 146 Egyptian sequences collected in 2003. It can also
be observed that the sequences from 1997 also cluster
together. This reflects a high evolutionary rate for the
viral sequences in the E1 region.
Figure 3 Evolutionary rate plot of the E1/E2 region for all the nucleotide sequences. The rate is computed using the program MEGA5. The
highly variable regions HVR1, HVR2, and HVR3 are highlighted. The rate is computed using the program MEGA5 using the default parameter. Sites
with rates larger than one are more variable than expected.
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E2 sequences isolated in 2006 and 2010 in addition to
our new ones. It is also clear that our sequences are
grouped together. The other sequences are clustered
separately. Although the data is not large enough to
yield a conclusion, it is most likely that E2 also evolves
at a high rate similar to E1, especially that it host the
highly variable regions.Estimation of clock rates for Egyptian sequences
To evaluate the molecular clock, we labeled the sequences
with the collection date and used the program BEAST.
The rate of change for E1 sequences was estimated to be
5.03E-3 per site per year, and that of E2 was 8.03E-3 per
site per year.Evolution of genotype 4a in non-Egyptian isolates
E1 Analysis
Exactly 218 E1 sequences from different countries in-
cluding our new 36 sequences were used to develop a
phylogenetic tree. After arranging the input sequences,
we computed the phylogeny and the rate of evolution
for each set separately. Figure 7 and Figure 8 show the
phylogenetic trees for the two E1 sequence sets includ-
ing our new 36 sequences. It can be clearly observedthat sequences from the same region cluster together in
separate sub-trees.E2 Analysis
We analyzed 155 E2 sequences from outside Egypt in
addition to the new sequences in this paper. The region
that is common among all of these sequences has been
identified and the subsequences including it were extracted.
The length of each sequence in the final set was 133 bp. In
our sequences in this paper, the common region starts at
position 618 and ends at position 740. Figure 9 shows the
phylogenetic tree for the 155 sequences from different
countries (including ours) which cover the E2 region. It can
be also observed that sequences from the same region clus-
ter together in separate sub-trees.Estimation of clock rates for non-Egyptian sequences
We have estimated the molecular clock and the rate of
change using the program BEAST as we explained be-
fore. The rate of change for the first set of E1 sequences
was 8.48E-3 per site per year, while it was 5.38E-3 for
the second set of E1. In fact, the rate of change for the
first part is not significant due to the small number of
the sequences and their short lengths. For E2, it was es-
timated to be 6.3E-3 per site per year.
Figure 4 Mean (relative) evolutionary rate plots of the E1/E2 region for each group separately. The rate is computed using the program
MEGA5 using the default parameter. Sites with rates larger than one are more variable than expected. All panels represents different patients
marked as A, B, C, D and E.
Table 3 Data of HCV E1 and E2 genotype 4 retrieved from data bases
Region Country Info Number of collected sequences
NCBI LANL EUHCV
E1 Egypt Collection dates range between 1997-2010 254 8 107
E2 Egypt Collection date ranged between 2006-2010 8 8 7
E1 Not-Egypt From Canada, France, Ireland, Pakistan, Sri Lanka, USA 182 13 120
E2 Not-Egypt From Ireland, USA 155 7 101
The analysis was made using the collection date of samples. These numbers does not include our 36 sequences, where the collection date of our sequences was 2011.
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Figure 5 The phylogenetic tree of the Egyptian E1 sequences isolated in the period from 1997 to 2011 and the new 36 sequences in
this study.
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Egypt has the highest endemic transmission and prevalence
of HCV in the world [8,27], The high degree of natural gen-
etic variation in HCV poses a significant challenge for anti-
viral chemotherapy and hinders the construction of effectiveFigure 6 The phylogenetic tree of the Egyptian E2 sequences
isolated in the period from 2006 to 2010 and the new 36
sequences in this study.vaccines against HCV [28]. The genetic divergence within
the region of envelope glycoprotein (E1/E2) of HCV is
mainly responsible for the variability of HCV genome [29].
Although there is a lot of work for sequencing HCV
genomes and analyzing them, very little work has beenFigure 7 The phylogenetic tree of the first set of E1 sequences
(covering the leftmost part of E1 region) including the Egyptian
sequences.
Figure 8 The phylogenetic tree of the second set of E1 sequences (covering the rightmost part of E1 region) including the Egyptian sequences.
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type 4, as can be observed by querying the different bio-
logical databases. Currently available data are highly
biased towards genotype 1. For example, 70% out of the
143 published distinct full genomes in the LANL HCVFigure 9 The phylogenetic tree of the E2 sequences including
the Egyptian sequences.database are of genotype 1, and 87% of these are specific
to subtype 1b. This emphasizes the substantial lack of
full genome sequences available for many of the HCV
genotypes and subtypes [15].
In the present study we present a new dataset includ-
ing sequences covering the whole E1/E2 region of HCV
genotype 4a. Specifically, we targeted the full range of
1672 bp of the E1/E2 region. Because the only previous
study [30] targeted only 105 bp of the E1/E2 region, the
current work is then the first of its type in terms of
coverage of the E1/E2 region.
Sequencing the E1/E2 region (HCV nucleotide pos-
ition 874 to 2551) from Egyptian isolates and sequence
analysis ascertains its high variability, even within the
same infected individual.
The analysis of variability across the E1/E2 sequence
sites is particularly interesting. First, it asserts that E1/E2
is in general a rapidly evolving region of the HCV gen-
ome, as previously studied in [31]. Second, it clearly
shows high degree of variability and the genetic diver-
gence codons at certain positions (Figures 1–4).
These areas mainly concentrated on the highly variable
regions. Interestingly, we could observe variable regions in
addition to HVR1 and HVR2. These newly observed ones
are in agreement with the previously reported regions in
[32] and named HVR495 and HVR575. It is worth men-
tioning that these two HVR regions were reported in sub-
types 4a but were not present in subtypes 1a, 1b, 2a, or 6a
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E1/E2 may reflect the generation of escape mutants as a
consequence of the immune response [34]. Such associa-
tions have been addressed in [35], where multiple variants
established infection in chimeric mice and selective sweep
has occurred after transmission of HCV.
Phylogenetic analysis of our new 36 sequences showed
that they are grouped into two main distinct groups: one
contains sequences (1D, 8E, 6B, 7A, 9D, 9A) which shows
noticeable degree of variability and another cluster that
contains a clade of sequences (4D, 5D, 1E, 7D, 3D, 10B,
5E, 2D, 2E, 6E) with no significant genetic heterogeneity
and high homology among the sequences. Similar study
on Phylogenetic tree reconstructions showed two distinct
clades existing within the 1a subtype with each clade hav-
ing a star-like tree topology [33].
Another group that arises into different branched and
sub clusters also showed variability among some se-
quences and homology between the sequences obtained
from patient C. In another analyses, we created independ-
ent phylogenetic tree to each group of sequences repre-
senting the same patient, which revealed a high degree of
genetic heterogeneity among the same infected individual
with different variants of HCV genotype 4a. An exception
for that was group C, which showed less variability.
We collected public sequences from different coun-
tries isolated at different time points. We studied their
variability and compared them to our new 36 sequences.
Our results confirm not only region specific variability
but also evolution of the sequences over the period of
study. In [39], the authors sequenced 36 samples from
10 HCV patients (Genotype 1a) over a period of 7–21
years. The patients were from the USA, Japan, and
Egypt. The sequences included 1,778 nucleotides from
the core gene, E1/E2, and the NS5b region. Phylogenetic
analysis of this dataset showed different geographical
distribution and spread times among the three countries.
In this study, the authors also discussed the related so-
cioeconomic, medical and paramedical events that can
be responsible for the spread of HCV infection in these
countries in the past [36]. Our results in this paper show
similar pattern for Genotype 4a, where sequences from
the same region and same time point tend to cluster to-
gether especially for the Egyptian sequences [37].
We would like also to indicate that our sequences are the
most recent ones, which also add temporal dimension to
this separation. It is most likely that E1 also evolves at a high
rate similar to E2, which hosts the highly variable regions.
It is clear how our Egyptian sequences cluster together in
a clear separation from the others. The other big Irish and
USA data has also been grouped together. These results sug-
gest a region specific evolution of the virus of this genotype.
Although the observed variability cannot be confirmed
as a prognostic tool in assessment of variants of acutehepatitis C course [38], it is likely related to functional and
immunological determinants of different HCV neutralizing
epitopes [11], viral transmission [30] and development of
hepatocellular carcinoma [39]. It is worth mentioning that
the present findings are compatible with our previously
published data on HCV-4 supporting viral genetic com-
plexity and variability in the 5’UTR region [40] and differ-
ent quasispecies that may play a role in the response to
IFN treatment [41]. Still, further studies using more data-
sets are needed to confirm E2 variability of HCV-4a and
whether it is related to the course of HCV infection or not.
The rate of change of E1 region within the Egyptian se-
quences from 1997 to 2012 has been estimated to be 5E-3
per site per year, and the rate of E1 for none Egyptian se-
quences was 5.38E-3 per site per year. For E2, the rate of
change was 8E-3 for Egyptian isolated and it was 6E-3 for
non-Egyptian isolates. Whether the rate of change differs
from one region to another or not remains an open ques-
tion that needs further validation using more datasets in
future.
Conclusion
Sequencing and phylogenetic analysis of 36 new se-
quences covering full region of E1/E2 region of HCV 4a
were conducted. Moreover, 254 E1 sequences and 8 E2
sequences isolated from Egypt in the period from 1997
to 2010 were collected. Also, 218 E1 sequences and 155
E2 sequences from different countries were collected
from public databases. Phylogenetic analysis of all these
datasets was conducted to study temporal and region
specific evolution of HCV-4a. The estimated rate of
change for Egyptian sequences was 5E-3 and 8E-3 per
site per year for E1 and E2, respectively. For non-
Egyptian sequences, the rates were 5.38E-3 and 6.3E-3
per site per year for E1 and E2, respectively. The results
of this study support the high rate of evolution of these
regions in genotype 4a. It has also revealed the signifi-
cant level of variability among sequences from different
regions of the world. Whether the clock rates do differ
from one region to another need further validation using
more datasets in future, especially for the E2 region. Fur-
ther research is also required to associate the observed
variability to functional issues, such as immune escape,
virulence, and disease pathogenesis.
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